Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13G/A | 2017-02-08 | WEXFORD CAPITAL LP | VIVEVE MEDICAL, INC. | 627,123 | 5.9% | EDGAR |
SC 13D/A | 2016-11-21 | STONEPINE CAPITAL, L.P. | VIVEVE MEDICAL, INC. | 2,599,711 | 24.4% | EDGAR |
SC 13D/A | 2016-06-24 | GBS Venture Partners Pty, Ltd | VIVEVE MEDICAL, INC. | 449,852 | 4.2% | EDGAR |
SC 13G | 2016-06-24 | LYTTON LAURENCE W | VIVEVE MEDICAL, INC. | 600,000 | 5.9% | EDGAR |
SC 13D/A | 2016-06-23 | Atkinson James G. | VIVEVE MEDICAL, INC. | 608,874 | 5.7% | EDGAR |
SC 13D/A | 2016-06-21 | STONEPINE CAPITAL, L.P. | VIVEVE MEDICAL, INC. | 2,599,711 | 25.5% | EDGAR |
SC 13D/A | 2016-06-21 | Alta Bioequities, L.P. | VIVEVE MEDICAL, INC. | 907,204 | 8.9% | EDGAR |
SC 13D/A | 2016-03-24 | STONEPINE CAPITAL, L.P. | VIVEVE MEDICAL, INC. | 18,397,682 | 30.7% | EDGAR |
SC 13G/A | 2016-02-16 | WEXFORD CAPITAL LP | VIVEVE MEDICAL, INC. | 3,416,987 | 5.7% | EDGAR |
SC 13G/A | 2016-02-09 | RTW INVESTMENTS, LLC | VIVEVE MEDICAL, INC. | 4,753,806 | 9.2% | EDGAR |
SC 13G/A | 2016-02-03 | ALPHA CAPITAL ANSTALT | VIVEVE MEDICAL, INC. | 740,444 | 1.2% | EDGAR |
SC 13D/A | 2015-12-21 | Atkinson James G. | VIVEVE MEDICAL, INC. | 3,916,079 | 6.6% | EDGAR |
SC 13D/A | 2015-12-03 | Atkinson James G. | VIVEVE MEDICAL, INC. | 3,702,997 | 7.2% | EDGAR |
SC 13D/A | 2015-12-02 | Alta Bioequities, L.P. | VIVEVE MEDICAL, INC. | 5,455,632 | 9.1% | EDGAR |
SC 13G | 2015-10-02 | RTW INVESTMENTS, LLC | VIVEVE MEDICAL, INC. | 3,591,378 | - | EDGAR |
SC 13D/A | 2015-06-01 | 5AM CO-INVESTORS II LP | VIVEVE MEDICAL, INC. | 7,310,231 | 14.4% | EDGAR |
SC 13D | 2015-05-22 | Atkinson James G. | VIVEVE MEDICAL, INC. | 2,702,702 | 5.3% | EDGAR |
SC 13D | 2015-05-21 | STONEPINE CAPITAL, L.P. | VIVEVE MEDICAL, INC. | 15,540,540 | 30.6% | EDGAR |
SC 13G | 2015-05-21 | WEXFORD CAPITAL LP | VIVEVE MEDICAL, INC. | 2,702,702 | 5.3% | EDGAR |
SC 13D/A | 2015-05-15 | Alta Bioequities, L.P. | VIVEVE MEDICAL, INC. | 4,598,490 | 9.1% | EDGAR |